Based on preclinical data on -ketoglutarate, Bryan takes 1 gram of it twice daily
For individuals with underlying health conditions such as obesity, type 2 diabetes, or metabolic syndrome, our providers can integrate discussions of TRT into your broader treatment plan, ensuring a cohesive approach to managing your health
The weight loss treatment plan creates a new, lower set point after you lose your weight goal amount
Bloating and dizziness occur less frequently but can be disruptive
During his fellowship at Johns Hopkins, he was involved with the first patient who was administered tissue plasminogen activator (t-PA) in 1984, a genetically engineered protein
Originally developed to treat type 2 diabetes, semaglutide has gained attention for its powerful effects on weight management as well